Last reviewed · How we verify
DFD-07 Cream
At a glance
| Generic name | DFD-07 Cream |
|---|---|
| Sponsor | Promius Pharma, LLC |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Eight Week Study of Treatment With DFD-07 for Actinic Keratosis of the Face and Scalp (PHASE2)
- A Study to Evaluate Two Concentrations of DFD-07 Cream, in Subjects With Actinic Keratosis (AK) of the Face and/or Scalp Over a 12-week Treatment Period (PHASE2, PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- DFD-07 Cream CI brief — competitive landscape report
- DFD-07 Cream updates RSS · CI watch RSS
- Promius Pharma, LLC portfolio CI